Identification of a Heparin Binding Domain in the Seventh Short Consensus Repeat of Complement Factor H

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5422-5427

  Blackmore, Timothy K ^a   Sadlon, Tania A ^a   Ward, Helena M ^a   Lublin, Douglas M ^b   Gordon, David L ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN; HEPARIN; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BINDING SITE; CHEMISTRY; CHO CELL; CONSENSUS SEQUENCE; GENE DELETION; HAMSTER; HUMAN; MOLECULAR CLONING; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; CHO CELLS; CLONING, MOLECULAR; COMPLEMENT FACTOR H; CONSENSUS SEQUENCE; CRICETINAE; HEPARIN; HUMANS; PROTEIN BINDING; RECOMBINANT PROTEINS; SEQUENCE DELETION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030589294     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Müller-Eberhard, H. J., and R. D. Schreiber. 1980. Molecular biology and chemistry of the alternative pathway of complement. Adv. Immunol. 29:1.
2. Pangburn, M. K., R. D. Schreiber, and H. J. Müller-Eberhard. 1977. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146:257.
3. Whaley, K., and S. Ruddy. 1976. Modulation of the alternative complement pathway by β1H globulin. J. Exp. Med. 144:1147.
4. Weiler, J. M., M. R. Daha, K. F. Austen, and D. T. Fearon. 1976. Control of the amplification convertase of complement by the plasma protein β1H. Proc. Natl. Acad. Sci. USA 73:3268.
5. Horstmann, R. D., M. K. Pangburn, and H. J. Müller-Eberhard. 1985. Species specificity of recognition by the alternative pathway of complement. J. Immunol. 134:1101.
6. Pangburn, M. K., M. A. L. Atkinson, and S. Meri. 1991. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 266:16847.
7. Edwards, M. S., D. L. Kasper, H. J. Jennings, C. J. Baker, and A. Nicholson-Weller. 1982. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J. Immunol. 128: 1278.
8. Stevens, P., S. N.-Y. Huang, W. D. Welch, and L. S. Young. 1978. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J. Immunol. 121:2174.
9. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986.
10. Fischetti, V. A., R. D. Horstmann, and V. Pancholi. 1995. Location of the complement factor H binding site on streptococcal M6 protein. Infect. Immun. 63:149.
11. Pangburn, M. K., D. C. Morrison, R. D. Schreiber, and H. J. Müller-Eberhard. 1980. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b. J. Immunol. 124:977.
12. Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122:75.
13. Fearon, D. T. 1978. Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA 75:1971.
14. Pangburn, M. K., and H. J. Müller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75:2416.
15. Ripoche, J., A. J. Day, T. J. R. Harris, and R. B. Sim. 1988. The complete amino acid sequence of human complement factor H. Biochem. J. 249:593.
16. Reid, K. B., and A. J. Day. 1989. Structure-function relationships of the complement components. Immunol. Today 10:177.
17. Koistinen, V. 1992. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement. Biochem. J. 283:317.
18. Cardin, A. D., and H. J. R. Weintraub. 1989. Molecular modelling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21.
19. Pekna, M., L. Hagman, E. Haldén, U. R. Nilsson, B. Nilsson, and S. Thelin. 1994. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann. Thorac. Surg. 58:421.
20. Fosse, E., O. Moen, E. Johnson, G. Semb, V. Brockmeier, T. E. Mollnes, M. K. Fagerhol, and P. Venge. 1994. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann. Thorac. Surg. 58:472.
21. Ovrum, E., T. E. Mollnes, E. Fosse, E. A. Holen, G. Tangen, M. Abdelnoor, M. L. Ringdal, R. Oystese, and P. Venge. 1995. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J. Thoracic Cardiovasc. Surg. 110:1623.
22. Cheung, A. K., C. J. Parker, J. Janatova, and E. Brynda. 1992. Modulation of complement activation on hemodialysis membranes by immobilized heparin. J. Am. Soc. Nephrol. 2:1328.
23. fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol. Cell Biol. 13:6385.
24. Vik, D. P., J. B. Keeney, P. Muñoz-Cánoves, D. D. Chaplin, and B. F. Tack. 1988. Structure of the murine complement factor H gene. J. Biol. Chem. 263: 16720.
25. Horton, R. M., Z. Cai, S. N. Ho, and L. R. Pease. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8:528.
26. Gordon, D. L., R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin. 1995. Identification of complement regulatory domains in human factor H. J. Immunol. 155:348.
27. Avery, V. M., and D. L. Gordon. 1993. Characterization of factor H binding to human polymorphonuclear leukocytes. J. Immunol. 151:5545.
28. Zammit, A., D. S. Pepper, and J. Dawes. 1993. Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma. Thromb. Haemost. 70:951.
29. Kuhn, S., C. Skerka, and P. F. Zipfel. 1995. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H. J. Immunol. 155:5663.
30. Schwaeble, W., E. Feifel, C. Estaller, A. Barbieri, M. Molgg, V. Koistinen, E. H. Weiss, and M. P. Dierich. 1991. Human complement factor H: molecular cloning and cDNA expression reveals variability in the factor H-related mRNA species of 1.4 Kb. Immunobiology 182:307.
31. Zipfel, P. F., and C. Skerka. 1994. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today 15:121.
32. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and non-activators of the alternative pathway of complement: regulation via a sialic acid/ polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87:3982.
33. Alsenz, J., J. D. Lambris, T. F. Schulz, and M. P. Dierich. 1984. Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38-kDa tryptic fragment of factor H. Biochem. J. 224:389.
34. Barlow, P. N., and I. D. Campbell. 1994. Strategy for studying modular proteins: application to complement modules. Methods Enzymol. 239:465.
35. Faham, S., R. E. Hileman, J. R. Fromm, R. J. Linhardt, and D. C. Rees. 1996. Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116.
36. Ecker, E. E., and P. Gross. 1929. Anticomplementary power of heparin. J. Infect. Dis. 44:250.
37. Sahu, A., and M. K. Pangburn. 1993. Identification of multiple sites of interaction between heparin and the complement system. Mol. Immun. 30:679.
38. Kazatchkine, M. D., D. T. Fearon, J. E. Silbert, and K. F. Austen. 1979. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b. J. Exp. Med. 150:1202.